H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 64 Citations 18,715 127 World Ranking 1440 National Ranking 32

Research.com Recognitions

Awards & Achievements

2002 - Member of Academia Europaea

Member of the European Molecular Biology Organization (EMBO)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Cancer

His main research concerns Immunology, MHC class I, Major histocompatibility complex, Natural killer cell and Interleukin 21. His Immunology study incorporates themes from Cytotoxic T cell and Cancer research. Klas Kärre interconnects CD1 and Cell biology in the investigation of issues within MHC class I.

His CD94/NKG2 study in the realm of Major histocompatibility complex interacts with subjects such as Class. His Natural killer cell course of study focuses on Immune tolerance and Cellular immunity and Genetic model. The various areas that Klas Kärre examines in his Interleukin 21 study include Receptor and Interleukin 12.

His most cited work include:

  • In search of the 'missing self': MHC molecules and NK cell recognition. (2156 citations)
  • Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy (1782 citations)
  • Association of class I major histocompatibility heavy and light chains induced by viral peptides. (874 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, MHC class I, Major histocompatibility complex, Molecular biology and Cell biology. His biological study spans a wide range of topics, including Cytotoxic T cell, Interleukin 12 and Natural killer cell. His work deals with themes such as Receptor, Cell and CD1, which intersect with MHC class I.

Major histocompatibility complex is a subfield of Immune system that Klas Kärre explores. Klas Kärre combines subjects such as In vitro, Virology, T cell, Lymphokine-activated killer cell and In vivo with his study of Molecular biology. His work carried out in the field of Cell biology brings together such families of science as Cancer cell, Genetics and Receptor expression.

He most often published in these fields:

  • Immunology (54.46%)
  • MHC class I (45.98%)
  • Major histocompatibility complex (30.36%)

What were the highlights of his more recent work (between 2011-2021)?

  • Immunology (54.46%)
  • MHC class I (45.98%)
  • Cell biology (24.55%)

In recent papers he was focusing on the following fields of study:

Klas Kärre focuses on Immunology, MHC class I, Cell biology, Cytotoxic T cell and Cell. His study explores the link between Immunology and topics such as Interleukin 12 that cross with problems in Natural killer T cell. His study on MHC class I is covered under Major histocompatibility complex.

His study in Cell biology is interdisciplinary in nature, drawing from both Cancer cell, Natural killer cell, Downregulation and upregulation and Antigen-presenting cell. His Cytotoxic T cell research is multidisciplinary, incorporating elements of Internal medicine and Lymphocyte. Klas Kärre interconnects Stem cell and Immune system in the investigation of issues within Cell.

Between 2011 and 2021, his most popular works were:

  • Classification of current anticancer immunotherapies (249 citations)
  • Human NK Cells Selective Targeting of Colon Cancer–Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules (143 citations)
  • Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice (133 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cancer

The scientist’s investigation covers issues in Immunology, Interleukin 21, Cytotoxic T cell, Cell biology and Cancer research. He combines topics linked to Cell with his work on Immunology. The concepts of his Interleukin 21 study are interwoven with issues in Granzyme and Interleukin 12.

In his work, Receptor is strongly intertwined with MHC class I, which is a subfield of Cell biology. His Cancer research research is multidisciplinary, relying on both Cell culture, Gut flora, Cell growth, NK-92 and Lymphokine-activated killer cell. His Immune system study incorporates themes from Cancer and Antigen.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

In search of the 'missing self': MHC molecules and NK cell recognition.

Hans-Gustaf Ljunggren;Klas Kärre.
Immunology Today (1990)

2901 Citations

Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy

Klas Kärre;Hans Gustaf Ljunggren;Gerald Piontek;Rolf Kiessling.
Nature (1986)

2362 Citations

Association of class I major histocompatibility heavy and light chains induced by viral peptides.

Alain Townsend;Claes Öhlén;Judy Bastin;Hans-Gustaf Ljunggren.
Nature (1989)

1152 Citations

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.

Hans-Gustaf Ljunggren;Klas Karre.
Journal of Experimental Medicine (1985)

1126 Citations

Empty MHC class I molecules come out in the cold

H G Ljunggren;N J Stam;C Ohlén;J J Neefjes.
Nature (1990)

1017 Citations

NK Cells, MHC Class I Molecules and the Missing Self

K. Kärre.
Scandinavian Journal of Immunology (2002)

371 Citations

Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice

Petter Hoglund;Claes Ohlen;Ennio Carbone;Lars Franksson.
Proceedings of the National Academy of Sciences of the United States of America (1991)

359 Citations

Classification of current anticancer immunotherapies

Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué.
Oncotarget (2014)

340 Citations

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

Tadepally Lakshmikanth;Shannon Burke;Talib Hassan Ali;Silvia Kimpfler.
Journal of Clinical Investigation (2009)

317 Citations

Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice

Claes Ohlen;Gunilla Kling;Petter Hoglund;Mona Hansson.
Science (1989)

308 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Klas Kärre

Lorenzo Moretta

Lorenzo Moretta

Bambino Gesù Children's Hospital

Publications: 145

Alessandro Moretta

Alessandro Moretta

University of Genoa

Publications: 128

Lewis L. Lanier

Lewis L. Lanier

University of California, San Francisco

Publications: 108

Eric Vivier

Eric Vivier

Aix-Marseille University

Publications: 97

Hans-Gustaf Ljunggren

Hans-Gustaf Ljunggren

Karolinska Institute

Publications: 97

David H. Raulet

David H. Raulet

University of California, Berkeley

Publications: 95

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 84

Peter Parham

Peter Parham

Stanford University

Publications: 77

Ofer Mandelboim

Ofer Mandelboim

Hebrew University of Jerusalem

Publications: 72

Maria Cristina Mingari

Maria Cristina Mingari

University of Genoa

Publications: 71

Karl-Johan Malmberg

Karl-Johan Malmberg

Oslo University Hospital

Publications: 68

Wayne M. Yokoyama

Wayne M. Yokoyama

Washington University in St. Louis

Publications: 66

Daniela Pende

Daniela Pende

University of Genoa

Publications: 59

Laurence Zitvogel

Laurence Zitvogel

Institut Gustave Roussy

Publications: 51

Cristina Bottino

Cristina Bottino

University of Genoa

Publications: 49

Massimo Vitale

Massimo Vitale

University of Genoa

Publications: 48

Something went wrong. Please try again later.